Developmentally toxic compounds
Negative controls Compound Conclusion of preliminary study on the rat.
2
The dose level of 75 mg/kg/day was concluded to be adverse to the developing foetus resulting in death and abnormality
3
Substantial effects on pregnancy and foetal development were seen at a dose level of 30 mg/kg/day.
5
No major or minor fetal malformations / abnormalities were observed at 200 & 400 mg/kg/day. At the limit dose of 1000 mg/kg/day, a single fetus was malformed. This could potentially be background variation.
6
Administration of the high dose of 300 mg/kg/day resulted in a slight, but not excessive, reduction in overall bodyweight gain for the treatment period and slight increases in pre-and post-implantation loss. Intra-animal variation was apparent and, in view of the small group sizes on this study, a relationship to treatment with 6 was considered to be unclear.
10
The major foetal abnormalities apparent at 200 and 500 mg/kg/day were considered to be related to maternal treatment with 10.
15
No evidence of maternal toxicity, but major malformations of fetuses were observed at 400 and 1000 mg/kg/day along with minor abnormalities across all doses. The findings from the study, including lower survival of fetuses, the higher number of malformations and the increase in fetuses with visceral variations compared to controls, lead to the conclusion that disruption to normal development was apparent following treatment with this compound.
Supplementary Table 2 . Conclusions of preliminary developmental toxicity studies in the rat. Preliminary to OECD guideline developmental toxicity studies were performed at a specialist contract research organization in the UK in accordance with all relevant legislation, ethical approvals and experimental best practice. Groups of 6-10 time mated female rats received AI by oral gavage daily for 19-21 days starting at day 5-6 of pregnancy. The vehicle and control was 0.5 % aqueous carboxymethycellulose. A constant dose volume of 10 mL/kg was used. All animals were examined for effects on general condition, body weight and food consumption and the progress and outcome of pregnancy. Blood samples were collected twice during gestation to demonstrate exposure to the test article. 
